Teladoc (TDOC) closed at $5.69 in the latest trading session, marking a -2.23% move from the prior day. The stock's change was less than the S&P 500's daily gain of 1.2%. At the same time, the Dow added 1.79%, and the tech-heavy Nasdaq gained 1.52%.
The stock of telehealth services provider has risen by 5.43% in the past month, leading the Medical sector's loss of 2.77% and the S&P 500's gain of 5.15%.
Investors will be eagerly watching for the performance of Teladoc in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on April 29, 2026. The company's earnings per share (EPS) are projected to be -$0.32, reflecting a 68.42% decrease from the same quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $612.3 million, down 2.71% from the year-ago period.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of -$0.89 per share and a revenue of $2.51 billion, indicating changes of +21.93% and -0.81%, respectively, from the former year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Teladoc. Recent revisions tend to reflect the latest near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Teladoc is currently sporting a Zacks Rank of #3 (Hold).
The Medical Services industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 89, placing it within the top 37% of over 250 industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
#1 Semiconductor Stock to Buy (Not NVDA)
The incredible demand for data is fueling the market's next digital gold rush. As data centers continue to be built and constantly upgraded, the companies that provide the hardware for these behemoths will become the NVIDIAs of tomorrow.
One under-the-radar chipmaker is uniquely positioned to take advantage of the next growth stage of this market. It specializes in semiconductor products that titans like NVIDIA don't build. It's just beginning to enter the spotlight, which is exactly where you want to be.
See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Teladoc Health, Inc. (TDOC): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).